Navigation Links
ev3 Inc. Appoints Shawn McCormick as New Sr. Vice President and Chief Financial Officer
Date:1/9/2009

PLYMOUTH, Minn., Jan. 9 /PRNewswire-FirstCall/ -- ev3 Inc. (Nasdaq: EVVV), a global endovascular device company, today announced the appointment of Shawn McCormick as Sr. Vice President and Chief Financial Officer, effective January 19, 2009. Mr. McCormick succeeds Patrick Spangler, who has resigned as Sr. Vice President and Chief Financial Officer effective January 19, 2009.

Mr. McCormick brings more than 15 years of experience in the medical device industry to ev3. He most recently served as Vice President, Corporate Development at Medtronic, Inc. where he was responsible for leading Medtronic's worldwide business development activities and previously had served in key corporate and divisional financial leadership roles within the Medtronic organization.

"We are very pleased to have someone with Shawn's experience join the ev3 management team," said Robert Palmisano, President and Chief Executive Officer of ev3. "His proven track record in financial management and business development will add tremendous value as we continue to focus on expanding our position in the peripheral vascular and neurovascular markets and delivering increased shareholder value. I would also like to thank Pat Spangler for his many contributions to ev3 over the past three and a half years. We wish him success in his future endeavors."

Mr. McCormick joined Medtronic in July 1992 and held various finance positions during his tenure. From May 2008 to January 2009, he served as Vice President, Corporate Development of Medtronic, Inc. From July 2007 to May 2008, he served as Vice President, Corporate Technology and New Ventures of Medtronic. From July 2002 to July 2007, he was Vice President, Finance for Medtronic's Spinal, Biologics and Navigation business. Prior to that, Mr. McCormick held various other positions with Medtronic, including Corporate Development Director, Principal Corporate Development Associate, Manager, Financial Analysis, Senior Financial Analyst and Senior Auditor. Prior to joining Medtronic, he spent almost four years with the public accounting firm KPMG Peat Marwick. Mr. McCormick earned his M.B.A. from the University of Minnesota's Carlson School of Management and his B.S. in Accounting from Arizona State University. He is a Certified Public Accountant.

About ev3 Inc.

Since its founding in 2000, ev3 has been dedicated to developing innovative, breakthrough and clinically proven technologies and solutions for the treatment of peripheral vascular and neurovascular diseases. ev3's products are used by endovascular specialists to treat a wide range of peripheral vascular and neurovascular diseases and disorders. The company offers a comprehensive portfolio of treatment options, including the primary interventional technologies used today -- peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization coils, thrombectomy catheters and occlusion balloons. More information about the company and its products can be found at http://www.ev3.net.

ev3 and the ev3 logo are trademarks of ev3 Inc., registered in the U.S. and other countries.


'/>"/>
SOURCE ev3 Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Amira Pharmaceuticals, Inc. Expands its Scientific Advisory Board and Appoints Dr. Paul Anderson, Professor Jerold Chun and Professor Andrew Tager
2. Hillenbrand, Inc. Appoints Jan Santerre Vice President of Lean Business
3. eDiets.com(R) Appoints Kevin N. McGrath as President and CEO
4. Bon Secours Charity Health System Appoints Terence M. O'Brien as Chief Executive Officer
5. Bat Saliva-Based Stroke Drug Disappoints in Trial
6. VirtualHealth Technologies, Inc. Appoints Former DEA Assistant Administrator to its Advisory Board
7. Sage Software Healthcare Appoints Kathleen Henry Senior Vice President, Customer Service
8. ABMS Appoints Richard Hawkins, MD, FACP as New Senior Vice President for Professional and Scientific Affairs
9. Aon Appoints Environmental Veteran to Oversee Risk Management Services for Clients in Far East, Asia and Australia
10. Glenwood Systems, LLC Appoints Ron Flormann Chief Commercial Officer
11. Hooper Holmes Appoints Marcus Mears President of Underwriting Solutions Division
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... 12, 2016 , ... Fisher House Foundation Chairman and CEO Kenneth Fisher joined ... Support Alliance president Scott Bensing, and Peggy Kearns Director, VA Southern Nevada Healthcare System ... This will be the first Fisher House in Nevada, and will provide free ...
(Date:2/12/2016)... ... 12, 2016 , ... Erlanger Agency has announced a new partnership in its ... campaign focuses on the fight against breast cancer, fundraising for a local woman named ... . , Carmen is a loving single mother of two boys who also serves ...
(Date:2/12/2016)... Lakeland, FL (PRWEB) , ... February 12, 2016 , ... ... Coast Dental hygienist Suzan Sweeney, RDH, and dental assistant Terrell Moore shortly before 7 ... They joined dozens of dental professionals, donating their time and skills to help hundreds ...
(Date:2/12/2016)... ... February 12, 2016 , ... Atlantic Information ... Health Plans and PBMs,” an upcoming Feb. 24 webinar that will discuss ways ... big-dollar therapeutic categories, such as the $1,000-per-pill hepatitis C treatment Sovaldi and high-cost ...
(Date:2/12/2016)... , ... February 12, 2016 , ... Healthcare careers in ... five most searched jobs via the website of healthcare staffing leader Aureus Medical Group ... travel nurse jobs , travel therapy positions and in travel and direct ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... , Feb. 11, 2016  Kindred Biosciences, Inc. (NASDAQ: ... and improving the lives of pets, today announced the ... the New Animal Drug Application (NADA) for Zimeta™ (dipyrone ... study (KB0120) of Zimeta for the control of pyrexia ... --> --> The ...
(Date:2/11/2016)... 11, 2016   Health 2.0 , the premiere ... technologies, announced today " 10 Year Global Retrospective ", ... over the past ten years.   ... Health 2.0 has served as the preeminent thought-leader in ... thousands of technologies, companies, innovators, and patient-activists through an ...
(Date:2/11/2016)... 2016  MiMedx Group, Inc. (NASDAQ: MDXG ), ... and other birth tissues, human skin and bone, and ... advanced products and therapies, announced today that it will ... Conference in New York , NY.  ... J. Senken , Chief Financial Officer and Chris ...
Breaking Medicine Technology: